is a functional neuropeptide derived from the evolutionarily conserved part of precursor protein secretogranin II (SgII). In the time course study, SN (10 nM) stimulates luteinizing hormone (LH) production and secretion after 6 h of static incubation of goldfish pituitary cells. Due to the existence of SN-immunoreactivity (SN-IR) in goldfish lactotrophs, endogenous SN might exert a paracrine effect on LH in the pituitary. In an in vitro immunoneutralization experiment, coincubation with anti-SN antiserum reduces the stimulatory effect of salmon gonadotropin-releasing hormone (sGnRH) on LH release by 64%. Using Western blot analysis, we demonstrate that sGnRH significantly increases the expression of the major SgIIderived peptide (ϳ57 kDa, with SN-IR) and prolactin (PRL) after 12 h in the static culture of goldfish pituitary cells. Furthermore, there exists a significant correlation between the levels of these two proteins (R ϭ 0.76, P ϭ 0.004). Another ϳ30 kDa SgII-derived peptide containing SN is only observed in sGnRH-treated pituitary cells. Consistent with the Western blot analysis results, real-time RT-PCR analysis shows that a 12-h treatment with sGnRH induced 1.6-and 1.7-fold increments in SgII and PRL mRNA levels, respectively. SgII gene expression was also associated with PRL gene expression (R ϭ 0.66; P ϭ 0.02). PRL cells loaded with the calcium-sensitive dye, fura 2/AM, respond to sGnRH treatment with increases in intracellular Ca 2ϩ concentration level, suggesting a potential mechanism of GnRH on PRL cells and thus SgII processing and SN secretion. Taken together, endogenous lactotroph-generated SN, under the control of hypothalamic GnRH, exerts a paracrine action on neighboring gonadotrophs to stimulate LH release.
lactotrophs [prolactin (PRL) cells] (36)
. The relatively high degree of conservation and wide distribution of the SN-immunoreactive SgII-derived peptide suggests that SN exerts various essential and biological actions in the neuroedocrine system. With regard to neuroendocrine systems controlling goldfish reproduction, our previous studies indicated that gfSN upregulates serum luteinizing hormone (LH) in vivo and at physiologically relevant concentrations (1-10 nM) directly stimulates LH release in vitro (1, 34, 36) .
The products derived from the SgII precursor that are immunoreactive for SN are released from rat gonadotrophs following in vitro gonadotropin-releasing hormone (GnRH) stimulation (5) . There exists a close correlation between the GnRHinduced release of SN-IR products and LH from the L␤T2 mouse gonadotropin cell line (20) . GnRH is a key hypothalamic neuropeptide regulating the production and release of several pituitary hormones controlling gonadal function in teleosts (30) . Goldfish 8 ]-GnRH (salmon GnRH or sGnRH), both of which regulate pituitary gonadotropin release via acting the GfA and GfB GnRH receptors (4, 10, 24) . The gonadotropins (GTHs) are classified as follicle-stimulating hormone (FSH) and LH. They are glycoproteins composed of a common ␣-subunit and a variable ␤-subunit that is specific to the hormone (26) . Both GnRH forms also induce the release of PRL from the tilapia pituitary (33) . Consistent with its effect in rat, a GnRH agonist is able to enhance the SgII mRNA expression in the pars distalis (PD) of goldfish anterior pituitary (25) . The GABA metabolism inhibitor ␥-vinyl-GABA can specifically stimulate SgII gene expression in goldfish pituitary, concomitant with a decrease of LH cellular content and an increase in serum LH, indicating a relationship between GABA-stimulated LH release and SgII production (1) .
Previous observations indicate that SN is found in lactotrophs but not gonadotrophs in the goldfish pituitary (36) , and thus the situation is different from that reported in rats. In the present study, we hypothesized that SN from lactotrophs is a paracrine neuropeptide-regulating gonadotroph. First of all, we performed a time course study of the effects of gfSN on the secretion and gene expression of various gonadotropin subunits in the static incubation of dispersed goldfish pituitary cells. The action of gfSN-antibody on sGnRH-stimulated LH release was investigated to test the hypothesis. Furthermore, we studied the effects of sGnRH on SgII processing concurrently with PRL production. To determine whether goldfish lactotrophs express functional GnRH receptors, we examined intracellular Ca 2ϩ dynamics in individual identified cells.
MATERIALS AND METHODS
Animals and tissue collection. Goldfish (Carassius auratus) purchased from Mt. Parnell Fisheries, Mercersburg, PA were handled according to protocols approved by the University of Ottawa Animal Care Committee as previously described (36) . Goldfish were anesthetized using 3-aminobutyric acid ethyl ester in water and killed by spinal transection; pituitaries were then removed from the skull and placed in ice-cold dispersion medium (M199 with Hank's salts, 25 mM HEPES, 26.2 mM sodium bicarbonate, 0.3% BSA, 100,000 U/l penicillin, 100 mg/l streptomycin, pH 7.2) for obtaining the dispersed pituitary cells.
Static incubation of dispersed goldfish pituitary cells and SN immunoneutralization.
A mixture of pituitaries from both males and females were collected at various times in the seasonal reproductive cycle and dispersed using Typsin type II and DNase II enzymes as previously described (3) . The time of collection of pituitaries for each in vitro cell culture experiment is indicated in the figure caption. An approximate yield is 4 ϫ 10 5 cells/pituitary. The cells were plated in 24-well culture plates at a density of ϳ2.5 ϫ 10 5 cells/well or 6-well culture plate at a density of ϳ5.0 ϫ 10 6 cells/well, and then cultured in plating medium (M199 with Earle's salts, 25 mM HEPES, 26.2 mM sodium bicarbonate, 1% horse serum, 100,000 U/l penicillin, 100 mg/l streptomycin, pH 7.2) under the conditions of 5% CO2, saturated humidity and 28°C. After an at least 12-h plating period, cells were washed with testing medium (M199 with Earle's salts, 25 mM HEPES, 26.2 mM sodium bicarbonate, 0.5% BSA, 100,000 U/l penicillin, 100 mg/l streptomycin, pH 7.2) and preincubated for 1 h to stabilize basal LH secretion. In previous studies, we showed that 10 nM gfSN stimulated LH release in vitro after 12-h static treatment (36) . To investigate the effect of gfSN on LH release at different time points, dispersed cells were exposed for 3-, 6-, and 12-h in static incubation. Media were then changed to testing medium consisting of either synthetic sGnRH (Glu-His-Trp-Ser-Tyr-Gly-Trp-Leu-Pro-Gly-NH2; 100 nM) or synthetic gfSN peptide (10 nM). In the SN immunoneutralization experiment (in October), pituitary cells in 24-well culture plates were preincubated for 2 h with anti-SN antiserum (1:750) or normal rabbit serum (NRS; at the dilution 1:750 as control). After 2 h, cells were subsequently treated for 12 h with either gfSN (10 nM) or sGnRH (100 nM). During the experiment, the concentrations of anti-gfSN antiserum and NRS remained at the dilution of 1:750. Following various static treatments, media samples were respectively collected and stored in Ϫ20°C for radioimmunoassay measurement of LH content. Total RNA and protein were isolated from the pituitary cells in six-well plates for the further analysis.
RIA. LH concentrations in incubation media were determined using a double antibody RIA (35) . Briefly, 96-well Dynamex Immulon 4 HBX Flat Bottom Microtiter plates (Thermo Labsystems, Milford, MA) were filled with 100 l rabbit anti-carp LH antibody (1:50,000), 50 l of LH standards (0.19 -100 ng/ml) or diluted sample (usually 1:100), and 25 l 125 I-labeled LH (ϳ18,000 cpm). All samples were assayed in triplicate. A group of six wells were filled with the same volumes of NRS (1:100) and 125 I-labeled LH as the blank to determine nonspecific binding. After 48 h incubation at 4°C, 50 l of goat anti-rabbit IgG (Scottish Antibody Product Unit, Scotland, UK) at a dilution of 1:10 was added to each well and incubated for an additional 24-h period at 4°C. Plates were centrifuged at 3,000 rpm and the supernatants were discarded. One hundred microliters of Optiphase Supermix (EG&G Wallac, Turku, Finland) scintillation fluid were then added to each well and incubated at room temperature for 4 h. Plates were counted in a Wallac Trilux Microbeta. WiaCalc software (version 2.60, EG&G Wallac) was utilized to estimate LH concentrations.
Dot immunoblotting analysis. Four microliters of 100 M gfSN and 100 M sGnRH were spotted onto the nitrocellulose membrane (Bio-Rad Laboratories, Hercules, CA) for dot immunoblotting analysis as previously described (36) . Briefly, after blocking nonspecific binding proteins, the membrane was incubated with anti-gfSN antiserum (35) at the dilution of 1:750 for 1 h. After that, it was reacted with ECL rabbit IgG horseradish peroxidase-linked whole antibody from donkey (dilution: 1:2,000, GE Healthcare, Buckinghamshire, UK) for 50 min, and then detected by using ECL plus Western blot analysis detection reagent (GE Healthcare). The peptide vehicle, water, was used as the blank control.
RNA isolation, cDNA preparation and real-time RT-PCR analysis. RNA was exacted using Trizol reagent (Invitrogen, Burlington, ON, Canada) or RNeasy Micro Kit (Qiagen, Hilden, Germany) following the company standard protocol. Total RNA concentration was measured by the GeneQuant spectrophotomer (Pharmacia Biotech, Qakville, ON, Canada). Two micrograms of RNA was at first treated by 2 units of RQ1 RNase-Free DNase (Promega, Madison, WI) to remove genomic DNA, at first, and then utilized to synthesize cDNA with 200 ng of random primers (Invitrogen, Carlsband, CA) and Superscript II RNase H Ϫ reverse transcriptase (Invitrogen). The original cDNA was diluted at the ratio of 0.1-0.01 for the PCR analysis. All primers were designed using Primer 3 (http://frodo.wi.mit.edu), verified by IDT OligoAnalyzer 3.1 (http://www.idtdna.com/analyzer/Applications/OligoAnalyzer) and generated by Invitrogen. The amplifications of gonadotropin-relevant genes were carried out with 150 -300 nM of primers (depending on different genes) in the Mx3000 Mulitplex Quantitative PCR System (Stratagene, La Jolla, CA). The PCR parameters were previously reported by our laboratory (17) and briefly described as a first cycle of Taq enzyme activation at 95°C for 10 min, followed by 40 cycles of 95°C for 30 s and 58°C for 5 s. A SYBR Green assay was used to measure the accumulation of PCR product for different genes. Results were analyzed by the Mx3000 Software Package. Standard curves relating initial template copy number to fluorescence and amplification cycles were generated and utilized to calculate mRNA copy number in each sample. 18S ribosomal RNA was chosen as a housekeeping gene in the SYBR Green real-time RT-PCR assay due to its statistically unchanged gene expression under various static treatments in vitro. The PCR product of each gene was purified by QIAprep Sprin Miniprep Kit (Qiagen) and sequenced to confirm the primer specificity. The primer sets utilized in this study were Goldfish GTH␣ (D86552: forward primer 5=-TTGGATGTGAGGAGTG-CAAA-3=, reverse primer 5=-GGTAAGCCCTAGAAAAACAGCA-3=); Goldfish FSH␤ (D88023; forward primer 5=-ATGCGCTTCGTTGTTAT-GGT-3=, reverse primer 5=-AGCTGCCACATTCCTCACTT-3=); Goldfish LH␤ (D88024; forward primer 5=-TGTGGAAAAGGAGGGCTGT-3=, reverse primer 5=-CAGTGGAAAATGGGCTCTTG-3=); Goldfish 18S (AF047349; forward primer 5=-AAACGGCTACCACATCCAAG-3=, reverse primer 5=-CACCAGATTTGCCCTCCA-3=); Goldfish SgII (AF046002; forward primer 5=-CCTCAGCCAGAGAACTCCAC-3=, reverse primer 5=-ATGCCTCTATCCATCCGAGA-3=); Goldfish PRL (S82197; forward primer 5=-GTGGCTGTTCTGATGTGT-3=, reverse primer 5=-CTGAAGAGAGGATGTGTG-3=).
Protein extraction and Western blot analysis of goldfish pituitary. Dispersed goldfish pituitary cells were homogenized in a buffer containing 20 mM HEPES, 200 mM sodium chloride, 0.1 mM EDTA, 10 mM sodium fluoride, 1 mM sodium metavanadate, 10 mM ␤-glycerophosphate and protease inhibitor cocktail (1:100; Bioshop Canada, Burlington, ON) and then centrifuged at 12,000 rpm for 15 min at 4°C. Total protein concentration of the supernatant was assayed by using NanoDrop ND-100 Spectrophotometer (Thermo Scientific, Wilmington, DE). As described previously (35) , pituitary extracts (ϳ15 g of total protein) were separated by electrophoresis on a 10% or 12% SDS-PAGE gel (10% or 12% bis-ascrylamide, 0.375 M Tris·HCl pH 8.8, 0.1% SDS, 0.1% ammonium persulfate, 0.04% TEMED) for SN-or PRL-IR assay, respectively. After electrophoresis, proteins were transferred onto polyvinylidene difluoride (PVDF) membrane (immobilon-P; Millipore, Bedford, MA). The membrane was blocked in the 20 mM Tris·HCl buffer (pH 7.5) containing 5% fat-free milk and 0.05% Tween 20, and then incubated with our previously validated primary goldfish SN antibody (35, 36, 1:700 dilution in blocking buffer), rabbit anti-carp PRL antibody (a gift from Dr. A. O. L.
Wong at the University of Hong Kong; 1:100,000 dilution in blocking buffer), and purified mouse anti-␤-actin monoclonal antibody (Cedarlane, Hornby, ON, Canada; at the dilution of 1:240) for ϳ12 h at 4°C. After the primary immunoreaction, the membrane was reacted with protein A-peroxidase (Sigma) at a dilution of 1:2,000 at room temperature for 90 min. After being washed, the membrane was covered with ECL plus Western blot analysis detection reagent (GE Healthcare, Buckinghamshire, UK) and then wrapped in plastic. Signals on the membranes were detected with the Bio-Rad ChemiDoc Imaging System and quantified using the Quantity One (Bio-Rad, Segrate, Milan, Italy) software package.
Calcium imaging. Changes in cytosolic-free intracellular Ca 2ϩ concentration ([Ca 2ϩ ]i) were monitored in identified lactotrophs cultured on poly-L-lysine-coated coverslips and preloaded with the Ca 2ϩ -sensitive dye fura 2-AM (Molecular Probes, Eugene, OR) as previously described (11, 32) . Lactotrophs in culture are easily identified under differential interference contrast microscopy because they have a diameter of ϳ10 -11 m, rough-granulated cytoplasm, a large centrally located nucleus of irregular shape occupying more than half of the cross-sectional area of the cell, and no apparent nucleolus (32) . Lactotrophs were excited at 340 and 380 nm wavelengths alternately using a computer-controlled filter wheel, and emission fluorescence of 520 nm was recorded. Treatment reagents were applied to cells housed in a closed bath imaging chamber (260-l chamber volume, series 20; Warner Instruments, Hayden, CT) using a gravity-driven perifusion system at a rate of 1 ml/min, allowing the bath solution to be replaced in ϳ16 s. Calcium levels were calculated as: concentration of free calcium in the cytosol ϭ dissociation constant X (F380max/ F380min)/[(R/Rmin)/(Rmax/R)], where dissociation constant ϭ 102 nm, F380max/F380min ϭ 3.11, Rmin ϭ 0.633, and Rmax ϭ 2.759, as obtained from a previously performed calibration. Data from each cell were quantified by normalizing the data to the average of the first five recording values, the pretreatment level, and then assessing net response as the area under the response curve with baseline subtracted (baseline value determined as an average value of five measurements before drug application). A response to drug application is considered to have occurred when a postapplication [Ca 2ϩ ]i measurement differs from the baseline by greater than twice the coefficient of variation (SD/mean ϫ 100) of pretreatment values. Treatments were replicated 15 times in separate experiments using three different cell preparations from goldfish having regressed gonads (December-January).
Data analysis. Results are presented as means Ϯ SE. The fold change represents the ratio of the means of two groups of data (i.e., treatment over control). The statistical analyses were performed using Sigma Stat version 3.5 software. For comparing multiple groups, one-way or two-way ANOVA was chosen as required to assess difference between various treatments, followed by a Fisher least significant difference test and the Student-Newman-Keuls method. In the comparison of two groups, a t-test was used to assess difference between control and treatment. A difference was considered to be significant if P Ͻ 0.05. Data were transformed by natural logarithms if they were not normally distributed. To determine the correlation between a pair of variables, the Spearman rank order correlation method was adopted. A correlation was considered to be statistically significant if P Ͻ 0.05.
RESULTS

Time course action of 10 nm gfSN on LH release from pituitary cells in vitro.
We performed a time course study to explore the effect of gfSN on LH release from dispersed pituitary cells from sexually mature goldfish. sGnRH (100 nM) and gfSN (10 nM) were administrated for 3, 6, and 12 h in a static incubation system (Fig. 1) . No significant effect of sGnRH was observed after the first 3-h incubation (P ϭ 0.064). However, the administration of 100 nM sGnRH enhanced LH levels by 3.4-and 3.1-fold, respectively, at the time point of 6th and 12th hour compared with the corresponding time-matched control (P Ͻ 0.05). Similar to the time-dependent pattern of sGnRH action on LH release, gfSN also did not affect LH release after the 3-h incubation. In contrast, the 6-and 12-h treatments of 10 nM gfSN induced significant increases of LH, which were 2.7-and 2.0-fold higher than the corresponding time-matched controls (P Ͻ 0.05).
Pituitary GTH␣, FSH␤, and LH␤ gene expressions are increased by gfSN. After either 6-or 12-h static incubation, the level of 18S ribosomal RNA was not modified by 10 nM gfSN (P Ͼ 0.05) and was therefore a suitable reference gene. The mRNA levels of GTH␣, FSH␤, and LH␤ were plotted as fold change with respect to the time-matched control values (Fig. 2) . The 6-h static treatment of 10 nM gfSN induced 1.25-, 1.34-, and 1.27-fold changes of GTH␣, FSH␤, and LH␤ mRNA (P Ͻ 0.05), respectively ( Fig. 2A) . At the end of 12-h incubation, the expression of these three genes remained somewhat elevated with treatment of 10 nM gfSN; however, these values were not statistically different from the corresponding control values (P Ͼ 0.05) (Fig. 2B) .
The anti-gfSN antibody reduced sGnRH stimulatory action on LH release. An SN-immunoneutralization experiment similar to the one previously described (36) was performed to determine whether gfSN mediates the actions of sGnRH to release LH in vitro. We first utilized dot immunoblots to confirm the specific binding ability of anti-gfSN antibody against gfSN but not sGnRH. Synthetic gfSN and sGnRH at the same concentration (100 M) were blotted and tested against the polyclonal anti-gfSN antibody. No signal was detected in the sGnRH position, whereas synthetic gfSN as the positive control exhibited a strong SN-IR signal (Fig. 3A) . Water served as a negative control (blank) and showed only a background level of the This experiment was performed in March at the beginning of the sexually mature prespawning period of goldfish. One-way ANOVA was chosen to assess the difference between control and treatment at a given time point, followed by a Fisher least significant difference test. Since the data of 12-h static incubation were nonparametric, the Kruskal-Wallis one-way ANOVA on ranks followed by the Student-Newman-Keuls method was adopted. *Significant difference from control at a given time point (P Ͻ 0.05).
immunoreaction. Consistent with the results in our previous study (36) , the administrations of sGnRH (100 nM) and gfSN (10 nM), respectively and similarly, elevated LH above basal levels by ϳ2.4-and 2.3-fold in NRS-treated groups (Fig. 3B) . However, in the presence of the anti-gfSN antiserum, sGnRH only induced a 1.5-fold increment of LH release, which represented only 64% of the LH release induced by sGnRH alone. Furthermore, the anti-gfSN antiserum completely blocked the stimulatory effects of gfSN (Fig. 3B) .
sGnRH enhances SgII processing and PRL protein expression. This experiment was performed to determine whether 12-h sGnRH (100 nM) exposure was able to affect SgII processing in cultured pituitary cells. The internal loading control for Western blot analysis was ␤-actin protein levels, and values were not significantly different between control and sGnRHtreated cells (Fig. 4, A and B) . Figure 4A shows the levels of SgII-derived peptides immunoreactive for SN. The intensities of ϳ57 kDa SgII products in the sGnRH treatment were significantly higher than those of the control (Fig. 4A) ; sGnRH induced 2.6-fold increment (P ϭ 0.002) of ϳ57 kDa SN-IR peptide (Fig. 4C) . Moreover, the other SgII-derived peptide (ϳ30 kDa) was only detected in sGnRH-exposed cells (lanes G1-G3 in Fig. 4A) but not in the control group, suggesting that sGnRH increased SgII processing to generate SN. In the same experiment, PRL protein levels were also modified in response to the 12-h sGnRH exposure (Fig. 4B) ; sGnRH significantly increased PRL by 1.9-fold (P Ͻ 0.05) compared with the control (Fig. 4C) . Furthermore, levels of the ϳ57 kDa SgII product were significantly correlated with the changes of PRL protein (R ϭ 0.76, P ϭ 0.004) as determined by Western blot analysis.
sGnRH increased SgII and PRL mRNA levels. The mRNA levels of SgII and PRL following 12-h static incubation of 100 nM sGnRH in goldfish pituitary cells were compared with the control (Fig. 5A) . The housekeeping gene, 18S ribosomal RNA was not significantly affected by sGnRH treatment (P Ͼ 0.05). Treatment with sGnRH induced 1.6-fold (P ϭ 0.006) and 1.7-fold (P ϭ 0.01) increments in SgII and PRL mRNA levels (Fig. 5A) , respectively. Moreover, SgII mRNA levels were significantly (R ϭ 0.66; P ϭ 0.02) correlated with PRL mRNA levels (Fig. 5B) . n ϭ 11) . The experiment was performed in October with sexually regressed goldfish. Two-way ANOVA followed by the Fisher least significant difference test was used to assess the effects of neuropeptides and antiserum on LH release. Different letters represent statistical differences (P Ͻ 0.05; Fisher least significant difference test). (10 nM) . The experiments of 6-h and 12-h were carried on in March (the beginning of the sexually mature prespawning period of goldfish) and October (the seasonal sexual regressive period of goldfish), respectively. Relative fold changes (means Ϯ SE) vs. the time-matched control were measured by real-time RT-PCR in A (n ϭ 9) and B (n ϭ 3-4). 18S ribosomal RNA was used for RNA loading control. *Significant difference between gfSN-treated cells and control at the end of 6-h incubation (t-test, P Ͻ 0.05). When the data were nonparametric, their natural logarithms were adopted before the t-test analysis.
sGnRH effect on [Ca 2ϩ ] i in identified lactotrophs. We monitored acute actions of sGnRH on [Ca 2ϩ ] i levels in lactotrophs preloaded with the calcium-sensitive dye fura 2/AM. Application of a 3-min pulse of sGnRH (100 nM) induced a significant increase above basal (469 Ϯ 237%) in [Ca 2ϩ ] i levels within individually identified PRL cells (Fig. 6 ). This indicates that sGnRH has a direct effect on lactotrophs.
DISCUSSION
Our previous time course study using goldfish pituitary fragments (34) and dispersed cells (36) in static incubation showed that gfSN stimulated LH release in vitro. In the present study, we also used dispersed cells to explore the effects of gfSN and sGnRH on hormone production and release. In this system, individual pituitary cells are more directly exposed to treatments, avoiding the possible influence of endogenous hypothalamic neuropeptides and neurotransmitter residues in the nerve fibers within pituitary fragments (3). We showed that C1, C2, and C3 ) and sGnRH (lanes G1, G2, and G3) groups. Total proteins isolated from the pituitary cells (ϳ15 g) were separated by 10% and 12% SDS-PAGE gel, respectively, and detected using the anti-gfSN antiserum (dilution: 1:2,000), anti-PRL antibody (dilution: 1:100,000), and anti-␤-actin antiserum (dilution: 1:240). Two SN-IR peptides, ϳ57 kDa and ϳ 30 kDa, are indicated by arrows. ␤-actin was used to control the total protein loading. C: data are presented as means Ϯ SE of the relative fold increase above the control for ϳ57 kDa SN-IR peptide and PRL expression (n ϭ 6). The t-test was used to compare control and sGnRH-treated pituitary cells for independent proteins. *Significant difference from control (P Ͻ 0.05). D: correlation of the change in ϳ57 kDa SgII product and PRL protein levels with and without sGnRH treatment. The data are normalized to ␤-actin protein levels. The correlation between these 2 variables is statistically significant (P Ͻ 0.01) as determined using the Spearman rank order correlation method. SN not only stimulated LH release but also moderately upregulated gene expression of GTH␣-, FSH␤-, and LH␤-subunits. An intriguing observation in this study is that the antigfSN antibody is capable of inhibiting the stimulatory effect of sGnRH on LH secretion from goldfish pituitary cells, suggesting a new paracrine pathway of lactotroph-sourced SN. In support of this hypothesis, we also demonstrated that sGnRH enhances SgII mRNA and SN-IR peptide levels, in parallel with the PRL gene and protein expression in cultured goldfish pituitary cells.
We showed that gfSN significantly stimulated LH release after 6 and 12 h, confirming previous in vitro experiments (36) . In the study of LH production, Klausen et al. (14) demonstrated that 12-h exposure to 100 nM sGnRH-enhanced LH␤-subunit gene mRNA levels in dispersed goldfish pituitary cells. In the same culture system, we showed that gfSN (10 nM) timedependently elevated LH␤ mRNA level by 1.27-fold. This moderate in vitro effect is consistent with the previous finding concerning the stimulatory effect for a higher dose of gfSN (500 nM) on the production of LH from goldfish pituitary fragments (35) . Furthermore, we also found that gfSN increased GTH␣-subunit mRNA levels after the 6-h incubation, providing further support for the effect of gfSN (10 nM) on LH production in the pituitary cell. In addition, 6-h treatment of gfSN (10 nM) induced 1.34-fold increase of FSH␤ mRNA level in dispersed goldfish pituitary cells, indicating its potential role to regulate FSH. Unfortunately, no specific FSH RIA exists for goldfish or any other cyprinid fish, so the effects of SN on FSH release cannot yet be determined. The gfSNevoked increments of GTH␣-subunit gene expression were similar to the previous data concerning the effects of sGnRH in the same static culture system (15) . Twelve-hour but not 24-h static treatment with sGnRH induced small but significant 17-42% increments of GTH␣-, FSH␤-, and LH␤-subunit mRNA levels in dispersed pituitary cells obtained from earlymiddle recrudescent goldfish (14, 15) . Similar to the stimulatory effect of sGnRH, the 6-h treatment with SN stimulated GTH subunit gene expression by 25-34% with respect to the control. Although SN only slightly increased LH␤ gene expression, SN induced a Ͼ 2.0-fold increase of LH secretion. The discrepancy between the levels of gene transcription and protein generation/release resulting from SN treatments may be indicative of increased activity of translational machinery in the gonadotroph. This was also reported in GnRH-induced LH production and release in mouse L␤T2 pituitary cells (19) . It was proposed that the acute response to GnRH stimulation led to activation of translation initiation proteins, including 4E-binding protein and eukaryotic initiation factors 4E and 4G via the signaling pathway of MAPK cascade in this cell line (19) .
Together, our results indicate similar LH-stimulating effects of gfSN and sGnRH, which suggests the existence of a functional relationship between these two neuropeptides. To further assess this possibility, we performed an immunoneutralization experiment to block the effects of SN secreted from dispersed goldfish pituitary cells during sGnRH stimulation. Our antigfSN antiserum in a Western blot analysis experiment was demonstrated to recognize the gfSN antigen, but not sGnRH, indicating that this antibody only neutralized SN. This is not surprising given that there is no sequence similarity whatsoever between SN and GnRH, which are 34 and 10 amino acid peptides, respectively. We found that the anti-gfSN antiserum completely blocked the stimulatory effects of SN on LH, indicating the effectiveness of the antibody. In the same experiment, the anti-gfSN antiserum significantly reduced sGnRH-stimulated LH release. Therefore, part of the stimulatory action of sGnRH is through the production of SN.
In our previous study of the anterior pituitary (36), a strong SN-IR signal was detected only in goldfish lactotrophs, indicating that the SN and PRL are produced in the same cells in the rostral PD (RPD). Stefano et al. (27) demonstrated for the first time, specific GnRH binding sites on the membranes of PRL cells of the pejerrey (Odontesthes bonariensis). In the RPD of the tilapia (Oreochromis mossambicus) pituitary, GnRH receptor type IB immunoreactivity had also been detected within the lactotrophs, suggesting that GnRH may regulate PRL production (23) . GnRH is therefore known to stimulate PRL production and secretion in tilapia and salmon (22, 33) . Our in vitro data are consistent with these previous observations and indicate that sGnRH also increased the PRL protein and gene expressions in the goldfish pituitary. Direct effects of GnRH on PRL cells are not limited to fish and have also been observed in sheep (9) .
Production of SgII, the SN precursor protein, is also modulated by GnRH in vertebrate neuroendocrine systems. GnRHstimulated SgII release in vitro was reported initially in female rat pituitary by Chanat et al. in 1988 (2) . Consistent with this result, it was demonstrated that 10 -1,000 nM GnRH showed a time-dependent action to enhance SgII secretion from dispersed rat pituitary cells, which was similar to LH and FSH responses to GnRH (5) . Furthermore, in an in vivo study, SgII and LH␤ mRNAs were downregulated in rat pituitary by GnRH antagonist treatments (13) . In the L␤T2 mouse gonadotroph cell line, pulsatile administration of GnRH not only elicited release of LH, FSH, and SN-IR SgII products but also upregulated the mRNA levels of their relevant genes. SgII release was associated with that of LH but not FSH secretion, indicating an association with the granin-related secretory pathway (20, 21) . Samia et al. (25) reported that in vivo injection of a sGnRH agonist increased SgII mRNA levels in the PD part of goldfish pituitary. Our in vitro findings presented here are in agreement with Samia et al. (25) , and we show that sGnRH elevated the SgII gene expression and the protein level of the major SgII product (a ϳ57 kDa SN-IR peptide) in static cultures of dispersed goldfish pituitary cells. These data provided the first in vitro evidence for a direct stimulatory action of GnRH on SgII production and processing in a teleost. We also demonstrate a close association between SgII and GnRH-stimulated PRL secretion. Considering the identification of free SN peptide in goldfish pituitary and strong SN immunoreactivity in the lactotrophs but not adjacent gonadotrophs or somatotrophs (36) , it is reasonable to propose that SN is generated within the lactotroph in association with PRL production.
It is likely that GnRH directly regulates lactotrophs, thereby controlling SN and PRL production. We found that sGnRH increases [Ca 2ϩ ] i in individual goldfish lactotrophs, supporting direct action of sGnRH on the PRL cell. The results are consistent with previous findings in tilapia where GnRH increased [Ca 2ϩ ] i in a rapid dose-dependent manner within dispersed lactotrophs, indicating GnRH-induced PRL secretion likely occurs via changes in [Ca 2ϩ ] i (28) . The present investigation further suggests that SN, along with PRL, might be generated and released from goldfish lactotrophs. This speculation is supported by previous data in mammals, in which calcium channel blockers were able to reduce SN release from several neuroendocrine cell types in vitro (29, 31) . These studies indicate that SN release in the vertebrate neuroedocrine system is [Ca 2ϩ ] i dependent. There is now evidence supporting both neuroendocrine and paracrine pathways for SN to stimulate LH secretion from goldfish gonadotrophs, which we summarize in Fig. 7 . This is, to our knowledge, the clearest example of an endocrine role for SN in any model system. Our previous findings concerning free SN peptide isolated from the brain, SN-IR located in the hypothalamus and pituitary nerve fibers, and GnRH-mimicking effect in vitro and in vivo (1, 34, 35, 36) strongly support the concept that brain-associated SN is a neuroendocrine factor to regulate LH release in the pituitary. The second important source of SN is the RPD of the goldfish pituitary (36) , where prolactin-producing cells form a distinct cell population adjacent to gonadotrophs that are located in the proximal PD. SN not only has moderate stimulatory effects on GTH␣-, LH␤-, and FSH␤-subunit mRNAs but also shows a time-dependent effect on LH release from dispersed goldfish pituitary cells in vitro. GnRH stimulates SgII processing concurrent with the PRL production in the goldfish pituitary, and an SN antibody reduces GnRH-stimulated LH. Therefore, the peptide SN is a new candidate in a growing list of important intrapituitary paracrine factors regulating hormone release (6 -8, 38) .
